Company Overview

Arsenal Medical, founded by George Whitesides and Robert Langer, is a platform technology company developing novel, therapeutic in-situ forming materials. In 2011, Arsenal Medical spun out Lyra Therapeutics to advance our clinical-stage drug delivery system that provides a steady dose of drug directly to diseased tissues.

June 5, 2017


U.S. FDA grants Arsenal Medical investigational device exemption approval to conduct clinical ResQFoam study


View Press Release

ResQFoam

Arsenal Medical’s in-situ forming polymeric foam, ResQFoam, is designed to control severe, intra-cavity hemorrhage by creating conformal contact and applying pressure to an actively bleeding site. Treatment consists of an injection of two liquid polymers that react upon combining to create a foam that expands rapidly through actively flowing blood to compress the injury and control bleeding.

Learn More